Last reviewed · How we verify
Frozen FluMist®
At a glance
| Generic name | Frozen FluMist® |
|---|---|
| Sponsor | MedImmune LLC |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older (PHASE1, PHASE2)
- Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older (PHASE1, PHASE2)
- Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older (PHASE1, PHASE2)
- A Clinical Study to Assess the Safety of a New Influenza Vaccine (PHASE4)
- A Study to Evaluate the Safety of a Monovalent Vaccine in Healthy Adults (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Frozen FluMist® CI brief — competitive landscape report
- Frozen FluMist® updates RSS · CI watch RSS
- MedImmune LLC portfolio CI